Market for Addiction Disorders to hit $3,8 billion by 2016, says New Report

Nov. 4, 2009 - PRLog -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing the market for addiction disorders.

“World Market for Addiction Disorders, 2009 – 2016: The Future Therapies for Substance Dependence and Impulse Control” estimates that the current market for addiction disorders is valued at $3.2 billion, and is forecast to increase 19% to $3.8 billion by 2016.

The report further examines the market for addiction pharmacotherapies currently estimated at $2 billion.

Supported by the success of Pfizer's recently launched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector -  pharmacotherapies in development for alcohol, narcotic, and nicotine dependencies - are estimated to radically change the addiction treatment landscape in this difficult-to-treat patient population.

Authors of the report introduces the reader to a specialty pharmaceutical market which is positioned for high-growth based on analysis of marketed and pipeline drugs, company activities, and addiction disorder demographics.

Included in this study are analyses of key therapy areas, R&D (Research and Development) programs, and innovating companies and products. Moreover, the reader will benefit from market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to stimulate growth and create new market opportunities.

“World Market for Addiction Disorders, 2009 – 2016: The Future Therapies for Substance Dependence and Impulse Control” is available from Piribo. For more information go to:  
http://www.piribo.com/publications/therapeutic/world_mark...

Piribo product ID: URC00168

# # #

About Piribo.
Piribo (http://www.piribo.com/publications/therapeutic/index.html) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 17,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.